Menu
Synergy in Action

9th Annual Scientific Meeting

plus 2013 ISCTM National Mental Health Research-to-Policy Forum
19 – 21 February, 2013   //   Washington DC, USA

Poster Awardee

Methodological issues on the impact of central nervous disorders or psychotropic drugs on driving performance as encountered by an alcohol reference study in driving simulation  (Kaussner, Y)

Day 1 (19 February 2013)

Presidential Welcome 
R Keefe
slides slides
video
2013 ISCTM National Mental Health Research-to-Policy Forum Chairs:
R Ferziger
video
R Manderscheid
Session 1: Post-Election Health Policy Outlook  
Introductions, Session Plan; Introduction of the Panelists S Dentzer
  The Post-Election Outlook for Healthcare Policy S Dentzer
slides slides
video
  Panel  
  Comments by Democrat Healthcare Policy Expert J Feder
  Comments by Republican Healthcare Policy Expert T Troy
  Mental Health Policy Priorities and Realizable Goals C Ingoglia
  Policy Outlook for Developing New Treatments and
for Access to New Treatments
K Buto
  What is Our Healthcare Policy Based On? R Manderscheid
    video (full panel)
  Audience Q/A; Moderated by S Dentzer  
Session 2: The Patient-Centered Outcomes Research Institute  
Session Plan and Introductions R Ferziger
video
  PCORI: History, Goals, Challenges, Potential Impact on Treatment Development J Selby
slides slides
  Discussion  
  Key Questions that PCORI Raises About the Use of Data From Clinical Trials for Policy Decision Making D Meltzer2
slides slides
video
  Discussion with Panelists  
  Industry R&D Perspective F Lewis-Hall
video
  Regulatory Perspective R Temple
  CMS/Payer Perspective S Tunis
slides slides
  Discussion; Q/A with All Speakers  
Forum Adjourns  
   
Developing Medicines to Treat CNS Side Effects: The Who, The What, The How, and The Why Chairs:
J Messina
J Tiller
  Treatment of Adverse Events: Some Background J Messina
slides slides
video
  Levodopa Induced Dyskinesia C Kenney3
slides slides
  Cognitive Dysfunction Associated with Cancer and Cancer Therapy J Wefel
slides slides
video
  Challenges to Developing Medicines to Treat CNS Side Effects R Marcus
slides slides
video
  Input from the FDA R Katz
slides slides
video
  Input from European Regulator K Broich
slides slides
video
Panel Discussion video
Reception  
Working Group Dinners  
  Adaptive Design Haynes
Report Back

slides slides
  Biomarkers Riordan
Potkin
Report Back

slides slides
  Cognitive Assessment in AD Posner
Harvey
Report Back

slidesslides
  Stimulant Dependence Palumbo
Kosten
Report Back
slides slides
  Suicidal Ideation and Behavior Stewart
Butler

slides workgroup slides
Report Back
slides slides
  Assessing Abuse Liability Potential Sokolowska
Klein
Setnik

slides workgroup slides
Report Back
slides slides
  Signal Detection Kalali
Report Back

slides slides

Day 2 (20 February 2013)

Andrew C. Leon Distinguished Career Award Presentation video
Reconceptualizing the Search for Treatments of the Schizophrenias in a Post-Bleulerian Era L Alphs
slides slides
video
M Davidson
  The Unmet Needs of Schizophrenia Treatment: A Clinician-Researcher’s Viewpoint M Davidson
slides slides
video
  A Drug Developer’s Viewpoint: The Changing Research Agenda – Making Strategic Decisions in 21st Century Development L Alphs
slides slides
video
  Is Schizophrenia a Disorder of Neurotransmitters? (If so, Why is Drug Discovery so Difficult?) D Goff
slides slides
video
  The Schizophrenias as Genetic Diseases: Implications for Design of Clinical Trials A Malhotra1,3
  The Schizophrenias as Circuit Diseases: Implications for Design of Clinical Trials A Voineskos
slides slides
S Potkin
slides slides
Voineskos/Potkin
video
  A Case Study: Novel Schizophrenia Development Program G Garibaldi
video
  Regulatory Implications for Novel Approaches to Developing Treatments for the Schizophrenias T Laughren
slides slides
video
  Panel Discussion slides slides
video
Parallel Sessions  
Session A: Methodological Issues in Assessing the Impact of CNS Drugs on Driving Performance Chairs:
T Macek
T Roth
  Introduction: The Relatedness of Sleepiness and Drug Effects on Driving Performance T Roth
slides slides
video
  Current Methodological Approaches to the Assessment of Driving Performance J Verster2
slides slides
video
  Innovative Methods to Assess the Risk of CNS Agents on Driving Performance: Statistical Approach E Laska
slides slides
video
  NHTSA Drugged Driving Expert Panel Report: a Consensus for Assessing the Potential of Drugs to Impair Driving R Compton
slides slides
video
  Regulatory Perspective R Farkas
slides slides
video
Session B: Pharmacotherapy for Facilitating Non-pharmacologic Treatments Chairs:
R Keefe
S Marder

slides slides
video
  Scientific Rationale for Drugs Enhancing Psychosocial Treatments D Goff
slides slides
video
  D-Cycloserine to Augment Behavior Therapy in Anxiety Disorders M Pollack2
slides slides
video
  Implementation Issues N DeMartinis
slides slides
D Walling
slides slides
DeMartinis/Walling
video
  Methodological and Statistical Issues R Hamer
slides slides
video
  Regulatory Issues T Laughren
slides slides
video
  Discussion S Marder
S Romano
  Poster Session / Reception Abstracts

Day 3 (21 February 2013)

Suicidal Ideation and Behavior: Methodological and Technical Challenges Chairs:
A Butler
M Stewart
R Meyer
  Introduction A Butler
slides slides
video
  A Review of the Findings of the ISCTM SIB Working Group; Study Site Experiences & Attitudes Toward Prospective Assessments of Suicidal Ideation and Behavior in Clinical Trials M Stewart
slides slides
video
  A Cross-sectional, Randomized, Non-interventional Methods Study to Compare Three Methods of Assessing Suicidality in Psychiatric Inpatients E Youngstrom
slides slides
video
  Results of a Prospective Validation for Mapping Three Suicidal Ideation and Behavior Assessment Instruments to the C-CASA L Alphs
slides slides
video
  Use of the C-SSRS in Clinical Trials: Predicting Short-Term Risk and Detecting Clinical Change G Brown
slides slides
video
  Methodological Approach to the Use and Interpretation of Baseline History of Suicidal Ideation and Behavior S DuBrava
slides slides
video
  Implementing Prospective Suicidality Assessments in Challenging Populations: An Alzheimer’s Disease Case Study V Coric
slides slides
video
  Summary/Discussant R Meyer
slides slides
video
  Panel Discussion Moderator:
A Butler
video
Meeting Adjourns  
(1) Slides not released.
(2) Released for Member Access only
(3) Video not released